UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 77

Sortiert nach

Efficacy and safety of oncolytic viruses in advanced or metastatic cancer: a network meta-analysis

Virology journal, 2021-07, Vol.18 (1), p.158-158, Article 158

2021

Volltextzugriff (PDF)

Long-term survival and prognostic factors for locally advanced renal cell carcinoma with renal vein tumor thrombus

BMC cancer, 2019-02, Vol.19 (1), p.144-144, Article 144

2019

Volltextzugriff (PDF)

Prognostic Significance of NLR About NETosis and Lymphocytes Perturbations in Localized Renal Cell Carcinoma With Tumor Thrombus

Frontiers in oncology, 2021-12, Vol.11, p.771545-771545

2021

Volltextzugriff (PDF)

The C228T mutation of TERT promoter frequently occurs in bladder cancer stem cells and contributes to tumorigenesis of bladder cancer

Oncotarget, 2015-08, Vol.6 (23), p.19542-19551

2015

Volltextzugriff (PDF)

Optimizing targeted drug selection in combination therapy for patients with advanced or metastatic renal cell carcinoma: A systematic review and network meta‐analysis of safety

Cancer medicine (Malden, MA), 2023-03, Vol.12 (6), p.7051-7064

2023

Volltextzugriff (PDF)

Copy number variation of urine exfoliated cells by low-coverage whole genome sequencing for diagnosis of prostate adenocarcinoma: a prospective cohort study

BMC medical genomics, 2022-05, Vol.15 (Suppl 2), p.104-104, Article 104

2022

Volltextzugriff (PDF)

Novel cut‐off values of time from diagnosis to systematic therapy predict the overall survival and the efficacy of targeted therapy in renal cell carcinoma: A long‐term, follow‐up, retrospective study

International journal of urology, 2022-03, Vol.29 (3), p.212-220

2022

Volltextzugriff (PDF)

Neutrophil extracellular traps primed intercellular communication in cancer progression as a promising therapeutic target

Biomarker research, 2023-03, Vol.11 (1), p.24-24, Article 24

2023

Volltextzugriff (PDF)

Promising Immunotherapy in Metastatic Testicular Sex Cord Stromal Tumours After First-Line Chemotherapy

Frontiers in immunology, 2022-01, Vol.12, p.720359-720359

2022

Volltextzugriff (PDF)

RNA-binding protein MEX3A controls G1/S transition via regulating the RB/E2F pathway in clear cell renal cell carcinoma

Molecular therapy. Nucleic acids, 2022-03, Vol.27, p.241-255

2022

Volltextzugriff (PDF)

Neutrophil extracellular traps in relationship to efficacy of systemic therapy for metastatic renal cell carcinoma

Cancer medicine (Malden, MA), 2023-12, Vol.12 (24), p.21807-21819

2023

Volltextzugriff (PDF)

Deaths and adverse events from adjuvant therapy with immune checkpoint inhibitors in solid malignant tumors: A systematic review and network meta‐analysis

Cancer innovation (Print), 2022-12, Vol.1 (4), p.293-304

2022

Volltextzugriff (PDF)

Neoadjuvant Chemotherapy-Guided Bladder-Sparing Treatment for Muscle-Invasive Bladder Cancer: Results of a Pilot Phase II Study

Cancer Research and Treatment, 2021, 53(4), , pp.1156-1165

2021

Volltextzugriff (PDF)

Role of DNA polymerases family members in cancer: The pan-cancer perspective

Journal of clinical oncology, 2021-01, Vol.39 (3_suppl), p.475-475

2021

Volltextzugriff (PDF)

Decision tree model with tumor immune function genes for predicting response to anti-PD1 therapy in renal cell carcinoma

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e17084-e17084

2020

Volltextzugriff (PDF)

Hot clear cell renal cell carcinoma immune status: Illusion or reality?

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e16575-e16575

2021

Volltextzugriff (PDF)

Targeting the deubiquitinase STAMBPL1 triggers apoptosis in prostate cancer cells by promoting XIAP degradation

Cancer letters, 2019-08, Vol.456, p.49-58

2019

Volltextzugriff (PDF)

PD18-02 NEUTROPHIL EXTRACELLULAR TRAPS IN RELATIONSHIP TO EFFICACY OF SYSTEMIC THERAPY FOR METASTATIC RENAL CELL CARCINOMA

The Journal of urology, 2024-05, Vol.211 (5S)

2024

Volltextzugriff (PDF)

PD43-09 PHENOTYPICAL SCREENING ONMETASTATIC PRCC-TFE3 FUSIONTRANSLOCATION RENAL CELL CARCINOMA ORGANOIDS REVEALSPOTENTIAL THERAPEUTIC AGENTS

The Journal of urology, 2022-05, Vol.207 (Supplement 5)

2022

Volltextzugriff (PDF)

MP28-11 LONG-TERM PROGNOSIS AND RISK STRATIFICATION FOR ADULT MIT FAMILY TRANSLOCATION RENAL CELL CARCINOMA

The Journal of urology, 2023-04, Vol.209 (Supplement 4)

2023

Volltextzugriff (PDF)

Front- and Rear-driving Patterns of Tumor Thrombus Progression in Clear Cell Renal Cell Carcinoma

European urology, 2022-10, Vol.82 (4), p.446-448

2022

Volltextzugriff (PDF)

Characteristics, dynamic changes, and prognostic significance of TCR repertoire profiling in patients with renal cell carcinoma

The Journal of pathology, 2020-05, Vol.251 (1), p.26-37

2020

Volltextzugriff (PDF)

PD51-07 ONCOLOGIC AND FUNCTIONAL EFFECTIVENESS OF NEOADJUVANT CHEMOTHERAPY FOLLOWED BY EITHER BLADDER-SPARING SURGERY PLUS CONCURRENT CHEMORADIOTHERAPY OR CYSTECTOMY FOR MUSCLE-INVASIVE BLADDER CANCER: PRELIMINARY RESULTS OF A PROSPECTIVE PHASE II STUDY

The Journal of urology, 2020-04, Vol.203, p.e1085

2020

Volltextzugriff (PDF)

Transmembrane Transporter Sema3D Serves as a Tumor Suppressor in Localized Clear Cell Renal Cell Carcinoma

Journal of oncology, 2022-06, Vol.2022, p.1-11

2022

Volltextzugriff (PDF)

Phenotypical screening on metastatic PRCC-TFE3 fusion translocation renal cell carcinoma organoids reveals potential therapeutic agents

Clinical & translational oncology, 2022-07, Vol.24 (7), p.1333-1346

2022

Volltextzugriff (PDF)

1 – 25 von 77

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(63)

Publikationsform

Artikel
(61)
Tagungsberichte
(16)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(53)
Life Sciences & Biomedicine
(29)
Technology
(23)
Humans
(18)
Oncology
(14)
Metastasis
(10)
Prognosis
(10)
Engineering
(9)
Male
(9)
Patients
(9)
Kidney Cancer
(8)
Materials Science
(8)
Materials Science, Multidisciplinary
(8)
Renal Cell Carcinoma
(8)
Robots
(8)
Medical Prognosis
(7)
Computer Science
(6)
Female
(6)
Middle Aged
(6)
Adult
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Efficacy and safety of oncolytic viruses in advanced or metastatic cancer: a network meta-analysis

Long-term survival and prognostic factors for locally advanced renal cell carcinoma with renal vein tumor thrombus

Prognostic Significance of NLR About NETosis and Lymphocytes Perturbations in Localized Renal Cell Carcinoma With Tumor Thrombus

The C228T mutation of TERT promoter frequently occurs in bladder cancer stem cells and contributes to tumorigenesis of bladder cancer

Optimizing targeted drug selection in combination therapy for patients with advanced or metastatic renal cell carcinoma: A systematic review and network meta‐analysis of safety

Copy number variation of urine exfoliated cells by low-coverage whole genome sequencing for diagnosis of prostate adenocarcinoma: a prospective cohort study

Novel cut‐off values of time from diagnosis to systematic therapy predict the overall survival and the efficacy of targeted therapy in renal cell carcinoma: A long‐term, follow‐up, retrospective study

Neutrophil extracellular traps primed intercellular communication in cancer progression as a promising therapeutic target

Promising Immunotherapy in Metastatic Testicular Sex Cord Stromal Tumours After First-Line Chemotherapy

RNA-binding protein MEX3A controls G1/S transition via regulating the RB/E2F pathway in clear cell renal cell carcinoma

Neutrophil extracellular traps in relationship to efficacy of systemic therapy for metastatic renal cell carcinoma

Deaths and adverse events from adjuvant therapy with immune checkpoint inhibitors in solid malignant tumors: A systematic review and network meta‐analysis

Neoadjuvant Chemotherapy-Guided Bladder-Sparing Treatment for Muscle-Invasive Bladder Cancer: Results of a Pilot Phase II Study

Role of DNA polymerases family members in cancer: The pan-cancer perspective

Decision tree model with tumor immune function genes for predicting response to anti-PD1 therapy in renal cell carcinoma

Hot clear cell renal cell carcinoma immune status: Illusion or reality?

Targeting the deubiquitinase STAMBPL1 triggers apoptosis in prostate cancer cells by promoting XIAP degradation

PD18-02 NEUTROPHIL EXTRACELLULAR TRAPS IN RELATIONSHIP TO EFFICACY OF SYSTEMIC THERAPY FOR METASTATIC RENAL CELL CARCINOMA

PD43-09 PHENOTYPICAL SCREENING ONMETASTATIC PRCC-TFE3 FUSIONTRANSLOCATION RENAL CELL CARCINOMA ORGANOIDS REVEALSPOTENTIAL THERAPEUTIC AGENTS

MP28-11 LONG-TERM PROGNOSIS AND RISK STRATIFICATION FOR ADULT MIT FAMILY TRANSLOCATION RENAL CELL CARCINOMA

Front- and Rear-driving Patterns of Tumor Thrombus Progression in Clear Cell Renal Cell Carcinoma

Characteristics, dynamic changes, and prognostic significance of TCR repertoire profiling in patients with renal cell carcinoma

PD51-07 ONCOLOGIC AND FUNCTIONAL EFFECTIVENESS OF NEOADJUVANT CHEMOTHERAPY FOLLOWED BY EITHER BLADDER-SPARING SURGERY PLUS CONCURRENT CHEMORADIOTHERAPY OR CYSTECTOMY FOR MUSCLE-INVASIVE BLADDER CANCER: PRELIMINARY RESULTS OF A PROSPECTIVE PHASE II STUDY

Transmembrane Transporter Sema3D Serves as a Tumor Suppressor in Localized Clear Cell Renal Cell Carcinoma

Phenotypical screening on metastatic PRCC-TFE3 fusion translocation renal cell carcinoma organoids reveals potential therapeutic agents

Suchergebnisse filtern